Welcome to our dedicated page for ASEP MED HLDGS news (Ticker: SEPSF), a resource for investors and traders seeking the latest updates and insights on ASEP MED HLDGS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ASEP MED HLDGS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ASEP MED HLDGS's position in the market.
Asep Medical Holdings Inc. (OTCQB: SEPSF) announced a joint venture with Sansure Biotech Inc. on January 27, 2023, aimed at commercializing the SepsetER sepsis diagnostic kit in China. The agreement, signed on September 29, 2022, outlines collaboration terms for research, development, and sublicensing in the Chinese market. Sansure will invest capital and Asep will receive royalties on sales. With a high sepsis mortality rate in China, this partnership is positioned to offer advanced diagnostic solutions, enhancing early detection capabilities while potentially reducing antibiotic resistance.
Asep Medical Holdings Inc. (CSE: ASEP, OTCQB: SEPSF) announced an online webinar on January 24, 2023, at 1:00 pm EST, to discuss global market developments, scientific advances, and investment milestones. Key topics include updates on the acquisition of SafeCoat Medical Inc., a joint venture with Bahrain's Seaspring W.L.L., and advancements in their sepsis diagnostic test kit, SepsetME. The webinar will also cover a feasibility study for an antibacterial mouthwash in China and the development of new wound bandages. The company aims to address significant medical needs associated with antibiotic failure.
FAQ
What is the current stock price of ASEP MED HLDGS (SEPSF)?
What is the market cap of ASEP MED HLDGS (SEPSF)?
